HU-320
HU-320
HU-320 (/ˈhjuː ˈθriːˈtwɛnti/) is a synthetic cannabinoid from the group of HU compounds. It is known for its potential therapeutic effects, particularly in the treatment of inflammation and autoimmune diseases.
Etymology
The term "HU" in HU-320 is derived from the initials of Hebrew University, where the compound was first synthesized. The number "320" is an arbitrary number assigned to this particular compound in the series of HU compounds.
Pharmacology
HU-320 is a potent CB2 receptor agonist. It has been shown to have anti-inflammatory and immunosuppressive effects, making it a potential therapeutic agent for the treatment of various inflammatory and autoimmune diseases. It does not have the psychoactive effects typically associated with cannabinoids, as it does not significantly interact with the CB1 receptor.
Related Terms
- Cannabinoid: A class of chemical compounds that act on cannabinoid receptors in cells.
- CB2 receptor: A type of cannabinoid receptor predominantly located in the immune system.
- Inflammation: A biological response to harmful stimuli, such as pathogens, damaged cells, or irritants.
- Autoimmune disease: A condition in which the immune system mistakenly attacks the body's own cells.
See Also
External links
- Medical encyclopedia article on HU-320
- Wikipedia's article - HU-320
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski